Drugs / Danshen Decoction
last change Dec 2019 re-read 9 days ago

Danshen Decoction

Developed for
intermediate coronary syndrome
Investigated by
Jun Li · Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Trials 2

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03171597 Aug 2017 → Oct 2019 intermediate coronary syndrome Jun Li Unknown No outcome recorded
Phase 4 NCT03179514 Jul 2017 → Oct 2019 intermediate coronary syndrome Jun Li Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Danshen Decoction ClinicalTrials.gov intervention name — accepted as the source's own label NCT03171597 ↗
1

NCT03179514 ↗